184 related articles for article (PubMed ID: 23647760)
1. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.
Berwouts D; Olteanu LA; Duprez F; Vercauteren T; De Gersem W; De Neve W; Van de Wiele C; Madani I
Radiother Oncol; 2013 Jun; 107(3):310-6. PubMed ID: 23647760
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of deformable image coregistration in adaptive dose painting by numbers for head-and-neck cancer.
Olteanu LA; Madani I; De Neve W; Vercauteren T; De Gersem W
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):696-703. PubMed ID: 22153223
[TBL] [Abstract][Full Text] [Related]
3. Adaptive dose painting by numbers for head-and-neck cancer.
Duprez F; De Neve W; De Gersem W; Coghe M; Madani I
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1045-55. PubMed ID: 20643512
[TBL] [Abstract][Full Text] [Related]
4. Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer.
Olteanu LA; Berwouts D; Madani I; De Gersem W; Vercauteren T; Duprez F; De Neve W
Radiother Oncol; 2014 Jun; 111(3):348-53. PubMed ID: 24746575
[TBL] [Abstract][Full Text] [Related]
5. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
Differding S; Sterpin E; Janssens G; Hanin FX; Lee JA; Grégoire V
Acta Oncol; 2016; 55(2):217-25. PubMed ID: 26079436
[TBL] [Abstract][Full Text] [Related]
6. Intensity modulated arc therapy implementation in a three phase adaptive (18)F-FDG-PET voxel intensity-based planning strategy for head-and-neck cancer.
Berwouts D; Olteanu LA; Speleers B; Duprez F; Madani I; Vercauteren T; De Neve W; De Gersem W
Radiat Oncol; 2016 Apr; 11():52. PubMed ID: 27039294
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of
Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
[TBL] [Abstract][Full Text] [Related]
8. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.
Madani I; Duprez F; Boterberg T; Van de Wiele C; Bonte K; Deron P; De Gersem W; Coghe M; De Neve W
Radiother Oncol; 2011 Dec; 101(3):351-5. PubMed ID: 21742392
[TBL] [Abstract][Full Text] [Related]
9. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia dose painting by numbers: a planning study.
Thorwarth D; Eschmann SM; Paulsen F; Alber M
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):291-300. PubMed ID: 17448882
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
Barragán AM; Differding S; Janssens G; Lee JA; Sterpin E
Med Phys; 2015 Apr; 42(4):2006-17. PubMed ID: 25832091
[TBL] [Abstract][Full Text] [Related]
12. Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.
Meijer G; Steenhuijsen J; Bal M; De Jaeger K; Schuring D; Theuws J
Radiother Oncol; 2011 Sep; 100(3):396-401. PubMed ID: 21955663
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study on adaptive
Schatteman J; Van Gestel D; Berwouts D; De Gersem W; De Kerf G; De Neve W; De Ost B; Olteanu AML; Rottey S; Vercauteren T; Goethals I; Duprez F
Strahlenther Onkol; 2018 Aug; 194(8):727-736. PubMed ID: 29556677
[TBL] [Abstract][Full Text] [Related]
15. Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Gouw ZAR; La Fontaine MD; Vogel WV; van de Kamer JB; Sonke JJ; Al-Mamgani A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):960-968. PubMed ID: 32361007
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.
Madani I; Duthoy W; Derie C; De Gersem W; Boterberg T; Saerens M; Jacobs F; Grégoire V; Lonneux M; Vakaet L; Vanderstraeten B; Bauters W; Bonte K; Thierens H; De Neve W
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):126-35. PubMed ID: 17448871
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.
Chang JH; Wada M; Anderson NJ; Lim Joon D; Lee ST; Gong SJ; Gunawardana DH; Sachinidis J; O'Keefe G; Gan HK; Khoo V; Scott AM
Acta Oncol; 2013 Nov; 52(8):1723-9. PubMed ID: 23317145
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting.
Houweling AC; Wolf AL; Vogel WV; Hamming-Vrieze O; van Vliet-Vroegindeweij C; van de Kamer JB; van der Heide UA
Radiother Oncol; 2013 Feb; 106(2):250-4. PubMed ID: 23395065
[TBL] [Abstract][Full Text] [Related]
19. Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using
Yan D; Chen S; Krauss DJ; Chen PY; Chinnaiyan P; Wilson GD
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):207-218. PubMed ID: 30684661
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
Rasmussen JH; Håkansson K; Vogelius IR; Aznar MC; Fischer BM; Friborg J; Loft A; Kristensen CA; Bentzen SM; Specht L
Radiother Oncol; 2016 Jul; 120(1):76-80. PubMed ID: 26993418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
